Medtronic plcMDTNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank15
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P15
Within normal range
vs 3Y Ago
-2.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q1 2026 | -4.24% |
| Q4 2025 | 3.86% |
| Q3 2025 | 6.14% |
| Q2 2025 | 1.33% |
| Q1 2025 | -3.16% |
| Q4 2024 | 3.11% |
| Q3 2024 | 0.15% |
| Q2 2024 | -2.88% |
| Q1 2024 | -0.43% |
| Q4 2023 | 4.49% |
| Q3 2023 | 4.54% |
| Q2 2023 | -7.12% |
| Q1 2023 | 1.78% |
| Q4 2022 | -2.31% |
| Q3 2022 | 6.13% |
| Q2 2022 | -0.76% |
| Q1 2022 | -2.81% |
| Q4 2021 | -9.87% |
| Q3 2021 | 18.67% |
| Q2 2021 | 5.16% |
| Q1 2021 | -5.95% |
| Q4 2020 | 2.90% |
| Q3 2020 | 9.52% |
| Q2 2020 | -1.05% |
| Q1 2020 | -4.98% |
| Q4 2019 | 2.73% |
| Q3 2019 | -1.18% |
| Q2 2019 | 5.88% |
| Q1 2019 | -4.92% |
| Q4 2018 | 0.85% |
| Q3 2018 | -1.18% |
| Q2 2018 | 5.90% |
| Q1 2018 | 0.54% |
| Q4 2017 | 1.46% |
| Q3 2017 | -0.90% |
| Q2 2017 | 4.34% |
| Q1 2017 | -4.33% |
| Q4 2016 | -0.36% |
| Q3 2016 | -3.30% |
| Q2 2016 | 5.31% |